AIM ImmunoTech Inc (NYSE American:AIM)
| 0.9205 Delayed Data As of May 27 |  +0.0005 / +0.05%Today’s Change | 0.55 Today|||52-Week Range 2.40 | +0.05% Year-to-Date |
Latest AIM News | Press Releases
No recent news for AIM ImmunoTech Inc.
Today’s Trading
| Previous close | 0.92 |
| Today’s open | 0.92 |
| Day’s range | 0.90 - 0.92 |
| Volume | 87,644 |
| Average volume (3 months) | 427,006 |
| Market cap | $47.6M |
Data as of 3:59pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | +10.66% |
| Earnings growth (this year) | +18.33% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -17.18% |
| P/E ratio | NM |
| Price/Sales | 322.61 |
| Price/Book | 0.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BYSIBeyondspring Inc | +0.17 | +15.04% |
| AGTCApplied Genetic Tech... | -0.02 | -2.72% |
| ZYNEZynerba Pharmaceutic... | +0.01 | +0.73% |
| APMAptorum Group Ltd | +0.05 | +4.10% |
Data as of 3:59pm ET, 05/27/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $135.0K |
| Annual profit (last year) | -$19.1M |
| Net profit margin | -14,168.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Ocala, Florida |
Forecasts
